Yixiang Mao

Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia

Zhimin Shao, Da Pang, Hongjian Yang et al. · JAMA Oncology · 2019 · 193 citations · Full text

Medicine, Oncology, Pharmacology +17

B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer

Yixiang Mao, Wei Li, Kai Chen et al. · Oncotarget · 2014 · 122 citations · Full text

Life Sciences, Immunology, Oncology +10

Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer

Chang Liu, Cathy Eng, Jianjun Shen et al. · Oncotarget · 2016 · 115 citations · Full text

Medicine, Cancer Biology, Oncology +17

RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer

Yixiang Mao, Jianjun Shen, Yue Lu et al. · Oncotarget · 2017 · 64 citations · Full text

Medicine, Molecular Biology, Oncology +17

Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin

Liu‐Mei Shou, Qiongyan Zhang, Wei Li et al. · Oncology Reports · 2013 · 60 citations · Full text

Medicine, Cell Biology, Oncology +17